Hui Jie

463 total citations
17 papers, 371 citations indexed

About

Hui Jie is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Hui Jie has authored 17 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Hui Jie's work include Plant-derived Lignans Synthesis and Bioactivity (4 papers), Epigenetics and DNA Methylation (3 papers) and Phytochemistry and Biological Activities (3 papers). Hui Jie is often cited by papers focused on Plant-derived Lignans Synthesis and Bioactivity (4 papers), Epigenetics and DNA Methylation (3 papers) and Phytochemistry and Biological Activities (3 papers). Hui Jie collaborates with scholars based in China, Denmark and United States. Hui Jie's co-authors include Li Zhu, Yu Zhao, Zhijun Zhang, Yu‐Lin Dong, Yinglan Zhao, Li Zhu, Yong‐Jing Gao, Zeping Zuo, Jie Xu and De‐Li Cao and has published in prestigious journals such as Molecules, Cancer Letters and European Journal of Medicinal Chemistry.

In The Last Decade

Hui Jie

16 papers receiving 365 citations

Peers

Countries citing papers authored by Hui Jie

Since Specialization

Citations

This map shows the geographic impact of Hui Jie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Jie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Jie more than expected).

Fields of papers citing papers by Hui Jie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Jie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Jie. The network helps show where Hui Jie may publish in the future.

Co-authorship network of co-authors of Hui Jie

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Jie. A scholar is included among the top collaborators of Hui Jie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Jie. Hui Jie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Serine starvation suppresses the progression of esophageal cancer by regulating the synthesis of purine nucleotides and NADPH 2025 ·Cancer & Metabolism ·Hui Jie, Jing Wei, (unknown), Min Yi, Xinying Qian, (unknown), Chunqi Liu, Chuan Li, Liang Wang, Pengchi Deng, Lunxu Liu, Xiaobo Cen, Yinglan Zhao	3
2	Global Trends in Ischemic Heart Disease Mortality from 1990 to 2021 and 2036 Projections: Insights from GBD 2021 Data 2025 ·Global Heart ·Xiaoqin Zhou, (unknown), Hui Jie, (unknown), (unknown), Jing Li, Ke Lin, Jing Lin	0
3	Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of ROS1+ or ALK+ non-small cell lung cancer to crizotinib therapy 2025 ·Translational Lung Cancer Research ·Hui Jie, (unknown), Zihuai Wang, Min Yi, Yi Liu, (unknown), Eric Santoni‐Rugiu, Shiyou Wei, (unknown), Chuan Li, (unknown), (unknown), Lunxu Liu, Senyi Deng, Chenglin Guo	1
4	Discovery of orally bioavailable ALK PROTACs based ceritinib against ALK positive cancers 2024 ·European Journal of Medicinal Chemistry ·(unknown), Mingxing Hu, Hui Jie, Yujue Li, Kexin Tang, Lili Pan, (unknown), Zi Liu, Wei Chen, Yuanwei Chen, Yi Luo, Youling Gong, Yongmei Xie	4
5	Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation 2021 ·Theranostics ·Chunqi Liu, Liang Wang, (unknown), Yuping Tan, Lei Tao, Yuzhou Xiao, Pengchi Deng, Huijuan Wang, (unknown), Yiyun Lin, Hui Jie, Huaqin Zhang, Jing Zhang, Yong Peng, Hu Zhang, Zong‐Guang Zhou, Qingxiang Sun, Xiaobo Cen, Yinglan Zhao	45
6	ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway 2019 ·Cancer Letters ·Yan Li, Lei Tao, Zeping Zuo, Yang Zhou, Xinying Qian, Yiyun Lin, Hui Jie, Chunqi Liu, (unknown), Huaqin Zhang, Hu Zhang, Xiaobo Cen, Shengyong Yang, Yinglan Zhao	31
7	Design and biological evaluation of tetrahydropyridine derivatives as novel human GPR119 agonists 2019 ·Bioorganic & Medicinal Chemistry Letters ·Zeping Zuo, Miaomiao Chen, Xiaoni Shao, Xinying Qian, (unknown), Xia Zhou, (unknown), Pengchi Deng, Yan Li, Hui Jie, Chunqi Liu, Xiaobo Cen, Yongmei Xie, Yinglan Zhao	7
8	Reprogramming of Lipid Metabolism in Cancer-Associated Fibroblasts Potentiates Migration of Colorectal Cancer Cells 2019 ·SSRN Electronic Journal ·Jin Gong, Yiyun Lin, Huaqin Zhang, Chunqi Liu, Zhong Cheng, Xiaowei Yang, Jiamei Zhang, Yuanyuan Xiao, Hui Jie, Na Sang, (unknown), Liang Wang, Xiaobo Cen, Xiao Du, Yinglan Zhao	5
9	1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice 2017 ·Oncology Reports ·Yan Li, Chunting Wang, Dandan Li, Pengchi Deng, Xiaoni Shao, Jing Hu, Chunqi Liu, Hui Jie, Yiyun Lin, (unknown), Xinying Qian, Huaqin Zhang, Yinglan Zhao	13
10	Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model 2015 ·Cell Death and Disease ·Fangfang Yang, Menglong Hu, Qianqian Lei, Yong Xia, Yongxia Zhu, Xiao Song, Yu Li, Hui Jie, (unknown), Ying Xiong, Zeping Zuo, (unknown), Lin Yu, Guohua Shen, (unknown), Yong Xie, (unknown), (unknown)	103
11	5-Methoxyquinoline Derivatives as a New Class of EZH2 Inhibitors 2015 ·Molecules ·Xiang Pu, Hui Jie, Yang Zhou, Bo Yang, Huijuan Wang, Jing Hu, Jian Hu, Shengyong Yang, Yinglan Zhao	11
12	Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors 2013 ·Bioorganic & Medicinal Chemistry ·(unknown), Zhitao Zhang, Hui Jie, Yu Zhao, Li Zhu	26
13	Synthesis and bioevaluation of novel arylnaphthalene lignans as anticancer agents 2012 ·Medicinal Chemistry Research ·Yu Zhao, Hui Jie, Li Zhu	13
14	Activation of astrocytes in the anterior cingulate cortex contributes to the affective component of pain in an inflammatory pain model 2011 ·Brain Research Bulletin ·(unknown), Yu‐Lin Dong, Zhijun Zhang, De‐Li Cao, Jie Xu, Hui Jie, Li Zhu, Yong‐Jing Gao	63
15	Synthesis and in vitro anticancer activities of novel aryl-naphthalene lignans 2011 ·Medicinal Chemistry Research ·Hui Jie, Yu Zhao, Li Zhu	17
16	Synthesis, Cytotoxicity and Pro-apoptosis of Novel Benzoisoindolin Hydrazones as Anticancer Agents 2010 ·Chemical and Pharmaceutical Bulletin ·Yu Zhao, Hui Jie, Dan Wang, Li Zhu, (unknown), Xiaodong Zhao	18
17	Synthesis and bioevaluation of novel analogues of justicidin A 2009 ·Medicinal Chemistry Research ·Yu Zhao, (unknown), Hui Jie, Li Zhu	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact